MedPath

A clinical study of Yastimadhu churna and Nagkeshar churna in the management of Raktapradara.(Excessive vaginal bleeding)

Phase 1/2
Not yet recruiting
Conditions
Diseases of the genitourinary system,
Registration Number
CTRI/2019/04/018709
Lead Sponsor
CARC Nigdi Pune
Brief Summary

This study is randomized clinical study parallel group comparing efficacy of Yastimadhu churna 3 gm twice a day and Nagkeshar churna 3 gm twice a day for 3 month in 70 patient of Rakt-pradara.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
35
Inclusion Criteria

Patient having lakshanas of raktapradara.

Exclusion Criteria
  • Known case of hypertesion.
  • known case of severe anemia.
  • known case of fiboid ,uterine cancer,genital tuberculosis.
  • Patient on harmonal replacement therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Compare the efficacy of Yastimadhu churna and Nagkeshar churna in the managment of Rakt-pradara.follow up for 3 months on 7th day of Menses in 3 cycles.
Secondary Outcome Measures
NameTimeMethod
To study the adverse effectif any.3 month

Trial Locations

Locations (1)

Dr Prachi Bhimrao Bhowate

🇮🇳

Pune, MAHARASHTRA, India

Dr Prachi Bhimrao Bhowate
🇮🇳Pune, MAHARASHTRA, India
Prachi Bhowate
Principal investigator
8806682808
prachibhowate@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.